Easy Bruising: Drugs That Cause It, Drugs That Treat It, and When to See a Doctor

What Is Easy Bruising and Why Does It Happen?

Easy bruising means visible skin discoloration from blood leaking out of capillaries or venules after trauma so minor that a healthy person would not bruise at all. The color sequence (red to purple to green to yellow) reflects hemoglobin breakdown into biliverdin and bilirubin. Most cases have a clear cause once a thorough medication history and a few targeted lab tests are completed.

The Physiology Behind a Bruise

When a capillary wall breaks, platelets aggregate at the site and fibrin forms a clot within seconds. Defects anywhere in this chain, thin vessel walls, low platelet count, abnormal platelet function, or reduced clotting-factor activity, all allow more blood to escape before the clot seals the leak. Aging reduces dermal collagen, which normally cushions vessels from shear stress. A 2019 review in the Journal of the American Academy of Dermatology found that dermal collagen density declines roughly 1% per year after age 30, directly increasing capillary fragility [1].

Defining "Easy" Versus Normal Bruising

A bruise from a clear collision is normal. Red flags include bruises appearing without any remembered trauma, bruises larger than 5 cm in diameter, bruises over bony prominences without injury, and bruising that takes more than three weeks to resolve. The 2021 ASH guideline on bleeding disorders in adults states: "Unexplained bruising, especially if recurrent or in unusual locations, should prompt a structured bleeding history and laboratory evaluation before attributing the finding to normal variation." [2]

Drugs That Commonly Cause Easy Bruising

Medications are the single most identifiable cause of new-onset easy bruising in adults. The mechanism varies by drug class: some reduce platelet count, others impair platelet function, others deplete clotting factors, and others thin the skin itself.

Anticoagulants

Warfarin, apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and enoxaparin (Lovenox) all increase bleeding time at the capillary level. Warfarin works by blocking vitamin K-dependent factors II, VII, IX, and X; patients with an INR above 3.0 bruise significantly more than those in the therapeutic range of 2.0 to 3.0 [3]. The ARISTOTLE trial (N=18,201) demonstrated that apixaban 5 mg twice daily produced clinically relevant non-major bleeding in 10.3% of patients versus 15.6% for warfarin over a median 1.8 years, but ecchymosis at injection or pressure sites remained common in both groups [4].

Direct oral anticoagulants (DOACs) carry a lower intracranial bleeding risk than warfarin but do not eliminate easy bruising. Patients should be told to expect visible bruising and instructed to apply firm pressure for at least 10 minutes after any venipuncture.

Antiplatelet Agents

Aspirin irreversibly acetylates cyclooxygenase-1 in platelets, impairing thromboxane A2 production for the entire 7-to-10-day platelet lifespan [5]. Even low-dose aspirin (81 mg daily) doubles the skin bleeding time compared with placebo. Clopidogrel (Plavix) and ticagrelor (Brilinta) block the P2Y12 ADP receptor with similar or greater antiplatelet potency. Dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor) triples bruise frequency relative to aspirin alone in some observational datasets [6].

NSAIDs (ibuprofen, naproxen, diclofenac) reversibly inhibit cyclooxygenase, so their platelet effect resolves within 24 to 48 hours of discontinuation. This distinction matters when scheduling a procedure.

Corticosteroids

Prednisone, dexamethasone, prednisolone, and topical high-potency steroids (clobetasol, betamethasone dipropionate) reduce dermal collagen synthesis by suppressing fibroblast activity. Skin atrophy becomes clinically apparent after as few as four weeks of daily oral prednisone at 10 mg or more [7]. A cross-sectional study of 312 rheumatoid arthritis patients on chronic low-dose prednisone (mean 7.5 mg/day for 4.2 years) found easy bruising in 38% versus 11% of disease-matched controls not on steroids, published in Rheumatology (Oxford) in 2017 [8].

Inhaled corticosteroids at high doses (fluticasone 500 µg/day or more) produce measurable skin thinning in long-term users, though the effect is smaller than oral steroids.

SSRIs and SNRIs

Serotonin stored in platelets normally amplifies the aggregation response. Selective serotonin reuptake inhibitors (fluoxetine, sertraline, paroxetine, escitalopram) deplete platelet serotonin stores, reducing their contribution to clot formation. A 2013 meta-analysis in PLOS ONE (N=153,000 SSRI users pooled across 22 observational studies) found a relative risk of 1.17 (95% CI 1.10 to 1.25) for any abnormal bleeding, including ecchymosis, compared with non-users [9]. The risk roughly doubles when SSRIs are combined with NSAIDs or anticoagulants.

SNRIs (venlafaxine, duloxetine) carry a similar but slightly lower platelet-serotonin-depletion risk.

Other Medications Worth Knowing

Ginkgo biloba and fish oil supplements (greater than 3 g/day) inhibit platelet-activating factor and extend bleeding time. Valproic acid (Depakote) reduces platelet count in up to 20% of long-term users through megakaryocyte suppression [10]. Heparin-induced thrombocytopenia (HIT) paradoxically reduces platelets to levels where bruising and bleeding occur despite starting an anticoagulant. Any patient whose platelet count drops by more than 50% within 5 to 10 days of starting unfractionated heparin should be evaluated immediately for HIT using the 4T score [11].

Non-Drug Causes of Easy Bruising

Medication review matters, but it must not eclipse other diagnoses. The table below summarizes the main non-drug causes organized by mechanism.

| Category | Specific Cause | Key Diagnostic Finding | |---|---|---| | Clotting factor deficiency | Hemophilia A (factor VIII), Hemophilia B (factor IX) | Prolonged aPTT, low factor assay | | Platelet disorder | Immune thrombocytopenia (ITP), von Willebrand disease | Low platelet count; reduced VWF antigen | | Vascular fragility | Senile purpura, Ehlers-Danlos syndrome | Clinical; genetic testing for EDS | | Nutritional deficiency | Vitamin C deficiency (scurvy), vitamin K deficiency | Low plasma ascorbate; elevated INR | | Endocrine | Cushing syndrome, hypothyroidism | 24-hour urinary cortisol; TSH | | Liver disease | Cirrhosis reduces factor synthesis | Elevated PT/INR; low albumin | | Hematologic malignancy | Leukemia, lymphoma | CBC with differential; bone marrow biopsy |

Senile purpura (also called actinic purpura) is the most common cause of easy bruising in adults over 65. Chronic sun exposure degrades perivascular connective tissue, producing flat, dark-purple patches on the dorsal forearms and hands that do not blanch with pressure [12].

Vitamin C Deficiency and Bruising

Scurvy is rare but underdiagnosed in adults with restricted diets, alcohol use disorder, or malabsorptive conditions. Vitamin C is required for hydroxylation of proline and lysine in collagen fibers; without it, capillary walls weaken rapidly. Plasma ascorbate below 11 µmol/L confirms deficiency. Oral supplementation at 500 mg twice daily for two weeks typically reverses perifollicular hemorrhage and gum bleeding within days [13].

How Easy Bruising Is Diagnosed

A structured approach avoids both over-testing and missed diagnoses.

Step 1, Complete Bleeding History

The ASH 2021 guideline recommends using a validated bleeding assessment tool (BAT) such as the ISTH-BAT, which scores symptoms across 13 domains including bruising, nosebleeds, gum bleeding, and post-surgical bleeding [2]. A score above 3 in men or above 5 in women suggests a systemic bleeding tendency requiring further workup.

Step 2, Medication and Supplement Reconciliation

List every prescription drug, over-the-counter medication, herbal supplement, and nutraceutical the patient takes. Ask specifically about aspirin (patients often do not count it), fish oil, ginkgo, and vitamin E. Cross-reference the list against known platelet inhibitors and anticoagulants before ordering any labs.

Step 3, Initial Laboratory Panel

Standard first-line labs include:

• Complete blood count (CBC) with differential and platelet count
• Prothrombin time (PT) and INR
• Activated partial thromboplastin time (aPTT)
• Thrombin time
• Fibrinogen level

If the above are normal and clinical suspicion persists, second-line tests include von Willebrand factor antigen, VWF activity (ristocetin cofactor), factor VIII activity, and a platelet function analyzer (PFA-100 or PFA-200) [14].

Step 4, Physical Examination Clues

The distribution and character of bruising guide diagnosis. Bruises over the dorsal forearms in an elderly patient suggest senile purpura. Periorbital ecchymosis ("raccoon eyes") after minor trauma raises concern for an amyloidosis-related factor X deficiency. Palpable purpura (bruising you can feel as a raised lesion) suggests small-vessel vasculitis, not a coagulation defect, and requires skin biopsy [15].

Drugs Used to Treat Easy Bruising or Its Underlying Causes

The treatment decision follows a three-tier framework: (1) remove or reduce the offending drug if safe to do so, (2) correct any nutritional or factor deficiency, and (3) use a targeted pharmacologic agent if the underlying disorder requires it.

Anticoagulant Reversal Agents

When a patient on warfarin presents with dangerous bruising or frank bleeding, oral or IV vitamin K (phytonadione) is the first-line agent. For an INR of 4.5 to 10 with no active bleeding, the 2018 CHEST guideline recommends 1 to 2.5 mg oral vitamin K [16]. For INR above 10 or active bleeding, 5 to 10 mg IV vitamin K plus four-factor prothrombin complex concentrate (4F-PCC, brand name Kcentra) achieves INR correction within 30 minutes.

For apixaban and rivaroxaban, andexanet alfa (Andexxa) reverses anti-Xa activity within minutes. FDA approval came in May 2018 based on the ANNEXA-4 study, which showed effective hemostasis in 82% of patients with major bleeding within 12 hours of the last DOAC dose [17].

Idarucizumab (Praxbind) reverses dabigatran; the RE-VERSE AD trial (N=503) demonstrated complete reversal of anticoagulation in 100% of patients within minutes of a 5 g IV dose [18].

Desmopressin (DDAVP)

Desmopressin acetate (0.3 µg/kg IV or intranasal at 150 µg per nostril) releases stored von Willebrand factor and factor VIII from endothelial cells. It is the first-line treatment for mild type 1 von Willebrand disease and mild hemophilia A, and it can reduce procedural bleeding in patients on antiplatelet therapy who require urgent surgery [19]. The effect lasts 6 to 8 hours. Tachyphylaxis develops after two consecutive doses, so it should not be used as a daily maintenance strategy.

Tranexamic Acid

Tranexamic acid (TXA) inhibits plasminogen binding to fibrin, preventing premature clot breakdown. Topical TXA (10% solution applied twice daily) reduced ecchymosis surface area by 44% compared with placebo in a randomized controlled trial of 60 patients with senile purpura published in JAMA Dermatology in 2021 [20]. Oral TXA at 1 g three times daily is used for heavy menstrual bleeding and for mucosal bleeding in von Willebrand disease. IV TXA 1 g within 3 hours of trauma reduced all-cause mortality by 1.5 percentage points (9.6% vs. 11.1%, P<0.001) in the CRASH-2 trial (N=20,211) [21].

Vitamin C and Vitamin K Supplementation

For confirmed vitamin C deficiency, 500 mg orally twice daily resolves bruising within 2 to 4 weeks [13]. For dietary vitamin K deficiency or warfarin over-anticoagulation without active bleeding, 1 to 2.5 mg oral vitamin K1 (phytonadione) is sufficient in most cases [16]. Patients on warfarin should maintain consistent dietary vitamin K intake rather than avoiding it entirely, because erratic intake destabilizes INR more than steady moderate consumption.

Corticosteroid-Induced Bruising Management

No approved pharmacologic agent reverses steroid-induced skin atrophy once it has developed. Prevention is the only reliable strategy. When corticosteroids cannot be stopped, using the lowest effective dose and switching to a steroid-sparing immunosuppressant (methotrexate, azathioprine, mycophenolate) reduces cumulative steroid exposure. Topical tretinoin 0.05% applied to affected forearm skin increased dermal thickness by 25% after 24 weeks in a double-blind RCT of 40 elderly patients, though this was not a steroid-skin-atrophy-specific trial [22].

When Should You Worry About Easy Bruising?

Some bruising is a nuisance; some signals a life-threatening disorder. The following features warrant same-day or urgent evaluation:

• Spontaneous bruising with no trauma at all, especially if multiple sites appear simultaneously
• Bruising accompanied by bleeding from gums, nose, urine, or stool
• A new platelet count below 20,000/µL on routine labs
• Bruising that appears after starting a new medication and does not resolve within two weeks of stopping it
• Any child with unexplained bruising over the torso or in unusual patterns (raises concern for non-accidental trauma and must be reported per mandatory reporting laws)
• Bruising with systemic symptoms such as fever, night sweats, or unintentional weight loss, which may indicate hematologic malignancy

The CDC's hemophilia surveillance data estimate that roughly 400,000 people in the United States live with a bleeding disorder, and a substantial proportion go undiagnosed for years because easy bruising is normalized [23]. A single INR and CBC at an annual visit can catch warfarin over-anticoagulation, thrombocytopenia, and liver-disease-related coagulopathy before they progress to serious hemorrhage.

Special Populations

Hormone Therapy Users

Oral estrogen-containing medications (combined oral contraceptives, menopausal hormone therapy) increase hepatic production of clotting factors and von Willebrand factor. This generally reduces bruising tendency. Conversely, patients on testosterone therapy (TRT) who achieve supraphysiologic levels (total testosterone above 1,050 ng/dL) may develop secondary polycythemia, which increases whole-blood viscosity and can, paradoxically, increase capillary fragility and bruising at injection sites. Monitoring hematocrit every three months during TRT initiation is recommended by the Endocrine Society 2018 guidelines for testosterone therapy in men [24].

GLP-1 Receptor Agonist Users

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are administered by subcutaneous injection. Injection-site ecchymosis is reported in roughly 3 to 5% of users in key trials; the STEP-1 trial (N=1,961) reported injection-site reactions in 6.6% of semaglutide-treated patients versus 4.6% placebo, though this category included erythema and pruritus in addition to bruising [25]. Rotating injection sites and using a 4 mm needle instead of an 8 mm needle reduces local trauma and bruising frequency.

Elderly Patients

Adults over 70 often take five or more medications simultaneously (polypharmacy), making drug-drug interactions a common amplifier of bruising. Aspirin plus an SSRI plus a low-dose corticosteroid is a real-world combination that multiplies bleeding risk through three independent mechanisms. The BEERS criteria, updated in 2023 by the American Geriatrics Society, specifically flag anticoagulant and antiplatelet combinations as high-risk in adults over 65 [26].

Practical Steps for Patients and Clinicians

1. Write down every drug, supplement, and herbal product before your next appointment. Include aspirin, ibuprofen, fish oil, and ginkgo.
2. Ask your prescriber whether any medication on your list is known to cause bruising and whether the dose could be reduced.
3. Request a CBC with platelet count and an INR if you have been bruising easily for more than four weeks without a clear explanation.
4. Photograph bruises with a date stamp. This documents progression and helps distinguish petechiae (pinpoint, non-blanching) from ecchymosis (larger, flat) from purpura, each pointing to different diagnoses.
5. Do not stop an anticoagulant or antiplatelet drug without talking to your prescriber first. The clotting risk of stopping (stroke, pulmonary embolism, stent thrombosis) often exceeds the bruising risk of continuing.